<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A girl, born in 1975, developed severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in November 1982 while on ethosuximide monotherapy for <z:e sem="disease" ids="C0014553" disease_type="Disease or Syndrome" abbrv="JAE">petit mal epilepsy</z:e>, about 3 months after starting the ethosuximide medication </plain></SENT>
<SENT sid="1" pm="."><plain>She was treated with bolus-<z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> as described by Bacigalupo et al </plain></SENT>
<SENT sid="2" pm="."><plain>(13), transfusions and antibiotics </plain></SENT>
<SENT sid="3" pm="."><plain>During the third week on this regimen slight improvements in granulocyte and reticulocyte counts were demonstrated, and after approximately 6 weeks she was in stable condition without further need of transfusions </plain></SENT>
<SENT sid="4" pm="."><plain>Blood status should be checked regularly during ethosuximide therapy, particularly during the first 6 months </plain></SENT>
</text></document>